Celularity Inc
(CELU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,354 | -44,278 | -19,754 | -57,892 | -44,599 |
| Depreciation Amortization | 5,441 | 3,668 | 1,834 | 7,922 | 6,046 |
| Accounts receivable | 7,003 | 2,458 | -1,350 | -3,968 | 1,054 |
| Other Working Capital | 25,732 | 19,044 | 4,285 | 22,200 | 12,451 |
| Other Operating Activity | 21,027 | 15,116 | 11,992 | 25,337 | 17,053 |
| Operating Cash Flow | $-8,151 | $-3,992 | $-2,993 | $-6,401 | $-7,995 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -161 | -70 |
| Net Acquisitions | N/A | N/A | N/A | -1,500 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 2,175 | 2,175 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $514 | $2,105 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 18,622 | 17,993 |
| Debt Issued | 9,098 | 891 | N/A | 6,000 | 6,000 |
| Debt Repayment | -6,969 | -221 | N/A | N/A | N/A |
| Common Stock Issued | 5,603 | 3,470 | 2,460 | 58 | N/A |
| Other Financing Activity | -303 | -189 | -140 | -17,979 | -17,935 |
| Financing Cash Flow | $7,429 | $3,951 | $2,320 | $6,701 | $6,058 |
| Beginning Cash Position | 10,977 | 10,977 | 10,977 | 10,163 | 10,163 |
| End Cash Position | 10,255 | 10,936 | 10,304 | 10,977 | 10,331 |
| Net Cash Flow | $-722 | $-41 | $-673 | $814 | $168 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,151 | -3,992 | -2,993 | -6,401 | -7,995 |
| Capital Expenditure | N/A | N/A | N/A | -161 | -70 |
| Free Cash Flow | -8,151 | -3,992 | -2,993 | -6,562 | -8,065 |